Click on a filter below to refine your search. Remove a filter to broaden your search.
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Significantly lower risks of chronic kidney disease and composite cardiovascular disease measure were seen for those with any remission.
Non-Hispanic Blacks, women and rural residents had more averted cardiovascular events and greater cost savings.
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Lifestyle and risk factor modification was recognized as pillar of a-fib management for preventing onset, progression and adverse outcomes.
Score had strong discriminatory accuracy in U.K. Biobank test sample and Whitehall cohort, with AUCs of 0.80 and 0.77
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.
No similar benefit was seen for resistance exercise alone in adults with overweight or obesity, however.